Subtopic Deep Dive
Hyperglycemia in Acute Myocardial Infarction
Research Guide
What is Hyperglycemia in Acute Myocardial Infarction?
Hyperglycemia in acute myocardial infarction refers to elevated blood glucose levels on admission or during hospitalization that independently predict increased mortality and adverse cardiac outcomes regardless of prior diabetes status.
Admission hyperglycemia occurs in up to 50% of AMI patients and associates with higher in-hospital mortality (Kosiborod et al., 2008, 384 citations). Multiple glucose assessments via glucometrics provide superior risk prediction over single measurements (Kosiborod et al., 2008). Consensus guidelines recommend tight glycemic control in hospitalized AMI patients (Moghissi et al., 2009, 1440 citations).
Why It Matters
Hyperglycemia on AMI admission enables risk stratification for intensified reperfusion and secondary prevention strategies, reducing mortality in both diabetic and non-diabetic patients (Kosiborod et al., 2008). Impaired glucose metabolism post-AMI predicts long-term mortality, guiding insulin therapy decisions (Bolk et al., 2001). Consensus statements outline inpatient glycemic targets to minimize complications like prolonged ventilation and infections (Moghissi et al., 2009). These insights improve outcomes in cardiac intensive care units handling over 1 million AMI cases annually worldwide.
Key Research Challenges
Optimal Glycemic Targets
Defining safe glucose ranges in AMI remains unresolved due to risks of hypoglycemia with intensive insulin therapy. Trials like HEART2D showed no outcome difference between prandial and basal glycemic control (Raz et al., 2009). Balancing inflammation reduction against hypoglycemia demands personalized metrics (Kosiborod et al., 2008).
Glucometrics Implementation
Routine use of multiple glucose measurements during AMI hospitalization faces logistical barriers in busy cardiac units. Kosiborod et al. (2008) demonstrated glucometrics outperform admission glucose for mortality prediction. Standardizing protocols across hospitals lags behind evidence.
Inflammatory Pathways
Hyperglycemia triggers pro-inflammatory cytokines in AMI, exacerbating myocardial damage, but insulin's anti-inflammatory effects require dosing optimization. Sun et al. (2014) linked hyperglycemia to organ damage via inflammatory mediators in critically ill patients. Distinguishing stress hyperglycemia from diabetes complicates therapy.
Essential Papers
American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control
Etie S. Moghissi, Mary T. Korytkowski, Monica M. DiNardo et al. · 2009 · Diabetes Care · 1.4K citations
4. Does inpatient management of hyperglycemia represent a safety concern? 5. What systems need to be in place to achieve these recommendations?6.Is treatment of inpatient hyperglycemia cost-effecti...
Standards of Medical Care in Diabetes—2007
Unknown · 2006 · Diabetes Care · 1.2K citations
Cardiovascular disease 1. Hypertension/blood pressure control 2. Dyslipidemia/lipid management 3. Antiplatelet agents 4. Smoking cessation 5. C o r o n a r y h e a r t d i s e a s e screening and t...
Standards of Medical Care in Diabetes–2006
American Diabetes Association · 2006 · Diabetes Care · 972 citations
Standards of Medical Care in Diabetes
Unknown · 2005 · Diabetes Care · 951 citations
Prevalence and Clinical Outcome of Hyperglycemia in the Perioperative Period in Noncardiac Surgery
Anna Frisch, Chandra Prakash, Dawn Smiley et al. · 2010 · Diabetes Care · 715 citations
OBJECTIVE Hospital hyperglycemia, in individuals with and without diabetes, has been identified as a marker of poor clinical outcome in cardiac surgery patients. However, the impact of perioperativ...
Glucometrics in Patients Hospitalized With Acute Myocardial Infarction
Mikhail Kosiborod, Silvio E. Inzucchi, Harlan M. Krumholz et al. · 2008 · Circulation · 384 citations
Background— Hyperglycemia on admission is associated with an increased mortality rate in patients with acute myocardial infarction. Whether metrics that incorporate multiple glucose assessments dur...
Effects of Prandial Versus Fasting Glycemia on Cardiovascular Outcomes in Type 2 Diabetes: The HEART2D trial
Itamar Raz, Peter W.F. Wilson, Krzysztof Strojek et al. · 2009 · Diabetes Care · 353 citations
OBJECTIVE—Hyperglycemia and Its Effect After Acute Myocardial Infarction on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus (HEART2D) is a multinational, randomized, controlled tr...
Reading Guide
Foundational Papers
Start with Moghissi et al. (2009, 1440 citations) for inpatient glycemic consensus, then Kosiborod et al. (2008, 384 citations) for AMI-specific glucometrics evidence.
Recent Advances
Raz et al. (2009) HEART2D trial on prandial vs. fasting control; Sun et al. (2014) on insulin's anti-inflammatory role in critical illness.
Core Methods
Glucometrics (time-averaged glucose, glycemic variability); consensus targets (140-180 mg/dL); insulin infusion protocols from ADA/AACE guidelines.
How PapersFlow Helps You Research Hyperglycemia in Acute Myocardial Infarction
Discover & Search
Research Agent uses searchPapers and citationGraph on 'hyperglycemia acute myocardial infarction' to map 384-cited Kosiborod et al. (2008) glucometrics work, revealing clusters around Moghissi et al. (2009) consensus. exaSearch uncovers Bolk et al. (2001) on glucose metabolism predicting mortality; findSimilarPapers expands to HEART2D trial.
Analyze & Verify
Analysis Agent applies readPaperContent to extract glucometrics data from Kosiborod et al. (2008), then runPythonAnalysis with pandas to recompute mortality odds ratios from glucose metrics. verifyResponse via CoVe cross-checks claims against Moghissi et al. (2009); GRADE grading scores consensus recommendations as moderate evidence for AMI glycemic targets.
Synthesize & Write
Synthesis Agent detects gaps in prandial vs. fasting control post-HEART2D (Raz et al., 2009) and flags contradictions in perioperative hyperglycemia outcomes (Frisch et al., 2010). Writing Agent uses latexEditText for guideline tables, latexSyncCitations for 1440-cited Moghissi paper, and latexCompile for polished reviews; exportMermaid diagrams inflammatory pathways from Sun et al. (2014).
Use Cases
"Analyze glucose-mortality associations in AMI using stats from Kosiborod 2008"
Research Agent → searchPapers → Analysis Agent → readPaperContent + runPythonAnalysis (pandas regression on glucometrics data) → mortality risk curves and p-values exported as matplotlib plot.
"Draft LaTeX review on glycemic consensus for AMI patients"
Synthesis Agent → gap detection → Writing Agent → latexEditText (insert Moghissi 2009 targets) → latexSyncCitations → latexCompile → camera-ready PDF with tables.
"Find code for AMI glucometrics risk models"
Research Agent → paperExtractUrls (Kosiborod 2008) → paperFindGithubRepo → githubRepoInspect → Python scripts for glucose trajectory modeling downloaded.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ AMI hyperglycemia papers, chaining searchPapers → citationGraph → GRADE grading for structured report on targets. DeepScan applies 7-step analysis with CoVe checkpoints to verify Kosiborod glucometrics against HEART2D data. Theorizer generates hypotheses on insulin anti-inflammation from Sun et al. (2014) linked to Bolk mortality predictions.
Frequently Asked Questions
What defines hyperglycemia in AMI?
Hyperglycemia in AMI is blood glucose ≥140 mg/dL on admission, predicting mortality independent of diabetes (Kosiborod et al., 2008).
What methods assess glycemic risk in AMI?
Glucometrics use multiple glucose measurements during hospitalization for better mortality prediction than single admission values (Kosiborod et al., 2008).
What are key papers?
Kosiborod et al. (2008, Circulation, 384 citations) on glucometrics; Moghissi et al. (2009, Diabetes Care, 1440 citations) on inpatient control; Raz et al. (2009) HEART2D trial.
What open problems exist?
Optimal insulin strategies balancing inflammation reduction and hypoglycemia risk; personalizing targets beyond consensus ranges (Moghissi et al., 2009; Sun et al., 2014).
Research Hyperglycemia and glycemic control in critically ill and hospitalized patients with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Hyperglycemia in Acute Myocardial Infarction with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers